Page 66 - 82_02
P. 66

Molecular modeling methodologies in the design, synthesis and rational explanation of results

     Mesoporous Materials 2010;132:559-66                           of trimethylsilyl-modified mesoporous material for
                                                                    controlled drug delivery. J Control Release
27. Doadrio JC, Sousa, EMB, Izquierdo-Barba I, Doadrio              2006;114:41-6.
     AL, Pérez-Pariente J, Vallet-Regí M.
     Functionalization of mesoporous materials with long       42. Gao L, Sun J, Zhang L, Wang J, Ren B. Influence of
     alkyl chains as a strategy for controlling drug delivery       different structured channels of mesoporous silicate on
     pattern. J Mater Chem 2006;16:462-6.                           the controlled ibuprofen delivery. Mater Chem Phys
                                                                    2012;135:786-97.
28. Van Speybroeck M, Barillaro V, Thi TD, et al.
     Ordered mesoporous silica material SBA-15: A broad-       43. Wan, MM, Sun XD, Li S, Ma J, Zhu JH. Versatile
     spectrum formulation platform for poorly soluble               drug releaser derived from the Ti-substituted
     drugs. J Pharm Sci 2009;98:2648-58.                            mesoporous silica SBA-15. Microporous Mesoporous
                                                                    Mater 2014;199:40-9.
29. Van Speybroeck M, Mellaerts R, Thao DT, et al.
     Preventing release in the acidic environment of the       44. Brás IR, Fonseca M, Dionisio M, Schönhals A,
     stomach via occlusion in ordered mesoporous silica             Affouard F, Correia NT. Influence of nanoscale
     enhances the absorption of poorly soluble weakly               confinement on the molecular mobility of ibuprofen. J
     acidic drugs. J Pharm Sci 2011;100:4864-76.                    Phys Chem C 2014;118:13857-68.

30. Zeng W, Qian, XF, Zhang YB, Yin J, Zhu ZK. Organic         45. Shena S, Nga W, Chiaa L, Hua J, Tan-Regínald BH.
     modified mesoporous MCM-41 through solvothermal                Physical state and dissolution of ibuprofen formulated
     process as drug delivery system. Mater Res Bull                by co-spray drying with mesoporous silica: Effect of
     2005;40:766-72.                                                pore and particle size. J Phys Chem 2011;115:23790-
                                                                    6.
31. Datt A, El-Maazawi I, Larsen SC. Aspirin loading and
     release from MCM-41 functionalized with                   46. Szegedi A, Popova M, Goshev I, Klebert S, Mihaly J.
     aminopropyl groups via co-condensation or                      Controlled drug release on amine functionalized
     postsynthesis modification methods. J Phys Chem C              spherical MCM-41. J Solid State Chem 2012;194:257-
     Nanomater Interfaces 2012;116:18358-66.                        63.

32. Huang S, Li C, Cheng Z, et al. Magnetic Fe3O4              47. Vallet-Regí M. Bio-ceramics with clinical
     mesoporous silica composites for drug delivery and             applications. India: Wiley 2014.
     bioadsorption. J Colloid Interface Sci 2012;376:312-
     21.                                                       48. Rehman F, Volpe P, Airoldi C. The applicability of
                                                                    ordered mesoporous SBA-15 and its hydrophobic
33. Gao L, Sun J, Yuzhen L. Functionalized bimodal                  glutaraldehyde-bridge derivative to improve
     mesoporous silicas as carriers for controlled aspirin          ibuprofen-loading in realising system. Colloids Surf B
     delivery. J Solid State Chem 2011;184:1909-14.                 2014;119:82-9.

34. Cavallaro G, Pierro P, Palumbo FS, Testa F, Pasqua         49. Hu Y, Wang J, Zhi Z, Jiang T, Wang S. Facile
     L, Aiello R. Drug delivery devices based on                    synthesis of 3D cubic mesoporous silica microspheres
     mesoporous silicate. Drug Deliv 2004;11:41-6.                  with a controllable pore size and their application for
                                                                    improved delivery of a water-insoluble drug. J Colloid
35. Tozuka Y, Arpansiree W, Kyoko K, Kunikazu M,                    Interface Sci 2011;363:410-7.
     Shigeo Y, Keiji Y. Effect of pore size of FSM-16 on
     the entrapment of flurbiprofen in mesoporous              50. Murzin DY, Heikkila T. Modeling of drug dissolution
     structures. Chem Pharm Bull (Tokyo) 2005;53:974-7.             kinetics with sigmoidal behavior from ordered
                                                                    mesoporous silica. Chem Eng Commun
36. Vallet-Regí M, Ramila A, del Real RP, Pérez-Pariente            2014;201:579-92.
     J. A new property of MCM-41: drug delivery system.
     Chem Mater 2001;13:308-11.                                51. Moritz M, Laniecki M. SBA-15 mesoporous material
                                                                    modified with APTES as the carrier for 2-(3-
37. Heikkila T, Salonen J, Tuura J, et al. Mesoporous               benzoylphenyl)propionic acid. Appl Surf Sci
     silica material TUD-1 as a drug delivery system. Int J         2012;258:7523-9.
     Pharm 2007;331:133-8.
                                                               52. Popova M, Szegedi A, Yoncheva K, et al. New
38. Muñoz B, Ramila A, Pérez-Pariente J, Diaz I, Vallet-            method for preparation of delivery systems of poorly
     Regí M. MCM-41 organic modification as drug                    soluble drugs on the basis of functionalized
     delivery rate regulator. Chem Mater 2003;15:500-3.             mesoporous MCM-41 nanoparticles. Microporous
                                                                    Mesoporous Mater 2014;198:247-55.
39. Song SW, Hidajat K, Kawi, S. Functionalized SBA-15
     materials as carriers for controlled drug delivery:       53. Carriazo D, del Arco M, Martín C, Ramos C, Rives V.
     influence of surface properties on matrix-drug                 Influence of the inorganic matrix nature on the
     interactions. Langmuir 2005;21:9568-75.                        sustained release of naproxen. Microporous
                                                                    Mesoporous Mater 2010;130:229-38.
40. Tang QL, Xu Y, Wu D, Sun YH. Hydrophobicity-
     controlled drug delivery system from organic              54. Ambrogi V, Perioli L, Marmottini F, Giovagnoli S,
     modified mesoporous silica. Chem Lett 2006;35:474-             Esposito M, Rossi C. Improvement of dissolution rate
     5.                                                             of piroxicam by inclusion into MCM-41 mesoporous
                                                                    silicate. Eur J Pharm Sci 2007;32:216-22.
41. Tang QL, Xu Y, Wu D, et al. Studies on a new carrier

@Real Academia Nacional de Farmacia. Spain                                                     183
   61   62   63   64   65   66   67   68   69   70   71